Form4.ai tracks every SEC insider trade in real time. See every MLYS insider filing with a free account — no card.

See every MLYS insider filing

Free account

Mineralys Therapeutics, Inc. (MLYS) Insider Trading

Mineralys Therapeutics, Inc. (MLYS) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 2 sales totalling $4.9M. Most recent filing: Oct. 20, 2026.

Bought vs sold

Open-market value, last 90 days

Sold: $4.9M (100%)
  • Sold $4.9M · 100%

What insiders filed

Form 4 filings by type, last 90 days

Sales: 2 (22%) Grants, exercises & other: 7 (78%)
  • Sales 2 · 22%
  • Grants, exercises & other 7 · 78%

At a glance

Insiders trading
8
Largest buy
—
Most recent filing
Oct 20, 2026

Latest MLYS Form 4 filings

Date Insider Trade Value Price since buy
Oct 20, 2026 SEC filing Peterson Kristine Director Grant / award — —
Oct 20, 2026 SEC filing COATS LONNEL Director Grant / award — —
Oct 2, 2026 SEC filing Congleton Jon Chief Executive Officer Sold $1,909,665 —

See every MLYS insider trade

Create a free account to see all 9 MLYS filings from the last 90 days. No card needed.

Create free account

Want MLYS insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days

Insiders are buying right now in other stocks too. See the latest insider trades across the market.

About this data

Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.